Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...

Universal access to GLP-1 receptor agonists for eligible populations could reduce global obesity prevalence by half and save ...

China-based MindRank’s oral glucagon-like peptide-1 receptor agonist (GLP-1RA) has achieved up to 10.5% weight loss in a ...

HANGZHOU, China and LONDON, UK I June 24, 2025 I MindRank, a clinical stage artificial intelligence (AI)-empowered drug discovery company, today announced ...